Nouhad Husseini

Senior Vice President, Business Development, Regeneron

Search every verified Nouhad Husseini interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Nouhad Husseini, Senior Vice President and Head of Business Development and Corporate Strategy at Regeneron, discussed the company's approach to partnerships and dealmaking in a November 2023 episode of the Business of Biotech podcast. He described deals as sometimes motivated by necessity, such as filling a pipeline gap or meeting revenue goals, but noted that Regeneron does not primarily organize its dealmaking around such perceived needs. He also cautioned against over-focusing on immediate execution, arguing that companies risk falling behind if they neglect investing in long-term innovation, particularly when successful technologies like Regeneron's VelocImmune attract copycats. Husseini also addressed common pitfalls in collaborations, attributing many failures to misaligned expectations between partners. He suggested that deals often go awry when parties enter agreements with differing assumptions about roles or intentions, such as one side expecting a larger role than the other intended. His remarks highlighted the importance of clarity and alignment in structuring partnerships.